Page 29 - தேசிய விரிவான புற்றுநோய் வலைப்பின்னல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Why people diagnosed with cancer should get a second opinion

A second opinion from a specialist who has extensive experience treating people with the type of cancer you’ve been diagnosed with can change or confirm your diagnosis.

University of south carolinaNational cancerNational comprehensive cancer networkMedical universitySouth carolinaNational cancer institute designatedபல்கலைக்கழகம் ஆஃப் தெற்கு கரோலினாதேசிய புற்றுநோய்தேசிய விரிவான புற்றுநோய் வலைப்பின்னல்மருத்துவ பல்கலைக்கழகம்தெற்கு கரோலினாதேசிய புற்றுநோய் நிறுவனம் நியமிக்கப்பட்ட

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaKangwon doBerge henegouwenArbeitsgemeinschaft internistische onkologieVan cutsemJapanese gastric cancer associationCancer genome atlas research networkEuropean society for medical oncologyChinese society of clinical oncologyNational comprehensive cancer networkRev dis primersPractice guidelinesChinese societyClinical oncologyClin oncol

Most Americans may have inadequate understanding of palliative care

The majority of surveyed Americans had an inadequate understanding of palliative care, and frequency of health care utilization was one determinant of knowledge.

United statesMotolani ogunsanyaEmily hendersonAmerican association for cancer researchUniversity of oklahoma health sciences centerAmerican society of clinical oncologyNational comprehensive cancer networkCancer epidemiologyAmerican associationOklahoma health sciencesAmerican societyClinical oncologyNational cancer instituteHealth information national trends surveyPalliative careHealth care

Antengene Announces Publication of Abstract on XPO1 Inhibitor Selinexor in Relapsed or Refractory Multiple Myeloma at ASCO 2021 and EHA 2021

Antengene Announces Publication of Abstract on XPO1 Inhibitor Selinexor in Relapsed or Refractory Multiple Myeloma at ASCO 2021 and EHA 2021 -Results from the MARCH trial showed an ORR of 33.3% in triple-class-exposed RRMM patients with the Sd regimen, and 44.4% in patients who previously received CAR-T therapies- -Selinexor is currently the only commercially available XPO1 inhibitor- News provided by Share this article Share this article SHANGHAI and HONG KONG, June 3, 2021 /PRNewswire/ Antengene Corporation Limited ( Antengene , SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, announced that the results from the Phase II MARCH trial of selinexor plus low dose dexamethasone (the Sd regimen) for the treatment of Chinese patients with relapsed or refractory multiple myeloma (RRMM) are published at the 2021 American Society o

United statesAsia pacificAntengene corporationAmerican society of clinical oncologyEuropean hematology associationDrug administrationPrnewswire antengene corporation limitedAntengene corporation limitedVirtual congressNational comprehensive cancer networkChinese society of clinical oncologyCorporation limitedClinical oncologyAnnual meetingHematology associationChinese society

Most US adults may lack knowledge about palliative care

E-Mail Bottom Line: The majority of surveyed Americans had an inadequate understanding of palliative care, and frequency of health care utilization was one determinant of knowledge. Journal in Which the Study was Published: Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research Author: Motolani Ogunsanya, PhD, an assistant professor at The University of Oklahoma Health Sciences Center Background: Palliative care aims to improve the quality of life for patients and caretakers by addressing the physical, psychological, and logistical challenges associated with a disease or its treatment. In contrast to hospice, which provides comfort care for patients who have stopped treatment and are near the end of life, palliative care serves as an adjunct to life-sustaining treatments by addressing the side effects of treatment or symptoms of the disease.

United statesMotolani ogunsanyaAmerican association for cancer researchUniversity of oklahoma health sciences centerAmerican society of clinical oncologyNational comprehensive cancer networkBottom lineCancer epidemiologyAmerican associationOklahoma health sciencesAmerican societyClinical oncologyNational cancer instituteHealth information national trends surveyMedicine healthHealth care systems services